School of Medicine
Showing 311-316 of 316 Results
-
Daphne P. Ly, MD, FACS
Affiliate
Current Research and Scholarly Interests1. Integrate machine learning with electronic health record system to improve work flow and achieve individualize cancer care based on current evidence.
2. Apply Cancer Genetics in cancer treatment and cancer risk reduction. -
Deirdre J. Lyell, M.D.
Dunlevie Endowed Professor of Maternal-Fetal Medicine
On Leave from 06/01/2024 To 06/30/2024Current Research and Scholarly InterestsPreterm labor prevention and management, preeclampsia prevention and treatment, short and long-term impact of surgical techniques at cesarean, depression during pregnancy, fetal heart rate monitoring and long-term neurologic outcome, randomized clinical trials.
-
David Lyons
Professor (Research) of Psychiatry & Behavioral Sciences (General Psychiatry and Psychology-Adult), Emeritus
Current Research and Scholarly InterestsBehavioral neuroscience
-
Zhonglin Lyu
Instructor, Neurosurgery
BioDr. Lyu is an instructor at the Department of Neurosurgery, Stanford University School of Medicine. He obtained his PhD at Soochow University, China, where he gained training in designing biomaterials to modulate stem cell behaviors and led multidisciplinary research under the advice of Prof. Hong Chen. During his PhD, he worked as a visiting student researcher at Canary Center for Early Cancer Detection at Stanford University School of Medicine where he gained training in microfluidics and cancer metastasis. Dr. Lyu carried out his postdoctoral research under the guidance of Prof. Jon Park and Wonjae Lee at the Department of Neurosurgery, Stanford University School of Medicine. He developed an in vitro microphysiological model of ischaemic stroke and used it as a platform to systematically evaluate the restorative potential of stem cell therapy.
As an instructor, Dr. Lyu's main research interest is to develop in vitro tissue/organ models to mimic human diseases including neurological diseases and cancer metastases. The goal is to use these models to understand disease mechanisms, to evaluate the safety and efficacy of existing drugs, and to look for new therapeutic targets.
